Pre-incubation of guinea-pig myenteric plexus with β-funaltrexamine: discrepancy between binding assays and bioassays
Open Access
- 19 July 1985
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 85 (3) , 665-673
- https://doi.org/10.1111/j.1476-5381.1985.tb10562.x
Abstract
1 The acute effects of β-funaltrexamine and the effects of pre-incubation with this compound were examined in five in vitro assay tissues and in selective binding assays in homogenates of guinea-pig brain and myenteric plexus. 2 In competitive displacement assays with selective ligands, β-funaltrexamine had highest affinity for the μ-binding site in the myenteric plexus and brain of guinea-pig. Its affinity for the k-site was about 15% of that for the μ-site. 3 Pre-incubation of the assay tissues with β-funaltrexamine caused an increase in the IC50 values of μ-and δ-receptor agonists but not of k-agonists. Although in bioassays on the myenteric plexus-longitudinal muscle preparation of the guinea-pig, the IC50 value of the μ-receptor ligand [D-Ala2, MePhe4, Gly-ol5] enkephalin was increased up to 124 fold, its binding at the μ-site in homogenates of the preparation was not affected by this treatment. 4 These findings indicate that the effects of pre-incubation with β-funaltrexamine on agonist potency of the μ-receptor ligand are due to an interference with the coupling mechanism between the μ-binding site and the effector system.This publication has 23 references indexed in Scilit:
- Species differences in the concentrations and distributions of opioid binding sitesEuropean Journal of Pharmacology, 1985
- Different receptor sites mediate opioid agonism and antagonismJournal of Medicinal Chemistry, 1983
- Application of an irreversible opiate antagonist (β-FNA, β-funal-trexamine) to demonstrate dynorphin selectivity for K-opioid sitesLife Sciences, 1982
- Improved assays for the assessment of ϰ- and δ-properties of opioid ligandsEuropean Journal of Pharmacology, 1982
- Rabbit vas deferens: A specific bioassay for opioid κ-receptor agonistsEuropean Journal of Pharmacology, 1981
- The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneEuropean Journal of Pharmacology, 1981
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the guinea pigEuropean Journal of Pharmacology, 1979
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973